Lung cancer: First-in-man phase I trial with lorlatinib

Lung cancer: First-in-man phase I trial with lorlatinibLung cancer: First-in-man phase I trial with lorlatinib, Published online: 15 December 2017; doi:10.1038/nrclinonc.2017.201Lung cancer: First-in-man phase I trial with lorlatinib

Source: Nature Clinical Practice Oncology - December 15, 2017 Category: Cancer & Oncology Authors: Diana Romero Source Type: research